facebook twitter linkedin
  • images/stories/slider.png
  • images/stories/slider2.png
  • images/stories/slider3.png
  • images/stories/slider4.png

NEWS RELEASES

  • Epidarex Capital Creates Nodthera Limited

    A pioneering new company based on Selvita research and utilizing novel immunological approaches to disease Edinburgh, Scotland, July 28, 2016: Epidarex Capital today announces the launch of Nodthera Limited, a new biotech company focused on the disc…

    Read More...

  • Selvita Inc. wins medicinal chemistry contract in San Francisco

    Kraków, Poland - July 11, 2016 - Selvita Inc., with headquarters in Cambridge, MA. and a Client based in San Francisco, CA, signed an agreement for drug discovery collaboration involving medicinal chemistry services. The contract will be carried out…

    Read More...

  • Selvita epigenetic project is the first Polish drug target program selected by EU Lead Factory

    Kraków, Poland – June 06, 2016 – The European Lead Factory, a scientific consortium dedicated to supporting the discovery of innovative medicines, has selected the first drug target program from Poland, to perform high throughput screening. The selec…

    Read More...